Obstructive sleep apnea syndrome as first manifestation of pharyngeal non-Hodgkin's lymphoma.
Obstructive sleep apnea syndrome (OSAS) is characterized by repetitive episodes of upper airway obstruction during sleep that provoke an abnormal number of apneas and hypopneas, leading to arousals and, as a result, to an altered sleep architecture. Here we present a patient with clinical symptoms characteristic of OSAS. During follow-up, pharyngeal non-Hodgkin's lymphoma was diagnosed and treated, with a nearly complete normalization of polysomnography.
Gómez-Merino
Elia
E
Sección de Neumología, Hospital Universitario San Juan de Alicante, Alicante, Spain. gomez_eli@gva.es
Arriero
Juan Manuel
JM
Chiner
Eusebi
E
Signes-Costa
Jaime
J
Marco
Juan
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000175:diagnosis* / Q000178:diet therapy; D008297:Male; D008875:Middle Aged; D010610:Pharyngeal Neoplasms / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D020181:Sleep Apnea, Obstructive / Q000209:etiology* / Q000628:therapy; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone